4baseCare has secured $6 million in a Series A funding round, with Yali Capital leading the investment.

Healthcare startup 4baseCare has secured $6 million in its Series A funding round, led by Yali Capital. The company plans to use the funds to enhance its product offerings and expand its operations across India and into other regions of Asia and the Middle East. Established in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare specializes in precision oncology solutions that leverage advanced genomics and digital health technology. The startup's genomic tests have already benefited over 10,000 cancer patients in Southeast Asia.

Among its offerings is Indiegene, which 4baseCare claims to be the world's first cancer gene panel specifically designed for biomarker testing in the Indian population. In the coming months, the company plans to establish genomics laboratories in the Philippines, Nepal, and Dubai. Additionally, 4baseCare aims to develop further genomics and digital health solutions, with a focus on advanced data analytics, improved clinical insights, and data-driven treatment recommendations.